Recent Posts
- New SAMHSA Publication: Current Research, Regulatory, and Policy Considerations Regarding Psychedelics as Medicine
- SAMHSA Releases Annual National Survey on Drug Use and Health
- Training Available – Controlled Drug Prescribing: Essential Aspects of Investigation
- FDA Proposes Rule to Modernize Drug Manufacturing Registration
- On April 23, 2026, the US Department of Justice released an update to the scheduling of FDA-approved marijuana products and products containing marijuana to Schedule III with federal controls.
Recent Comments
No comments to show.
